TKT and chronic myelogenous leukemia, BCR-ABL1 positive: CML LSCs evade from TK inhibitor-induced death through multiple pathways, including micro-environmental niche regulatory molecules, Hedgehog (Hh), WNT, polycomb gene BMI1 and Notch [6].